Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts

Nature
|March 19, 1981
PubMed

Insights

Tumor DNA from various tissues and species can transform NIH3T3 cells, indicating that cancer-causing genes can cross species and tissue barriers. This study explores the cross-species and cross-tissue transforming potential of tumor DNA.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Previous studies showed that DNA from 3-methylcholanthrene (3-MC)-transformed mouse fibroblasts induces transformation in NIH3T3 cells.
  • These findings suggested that specific DNA sequences encode the transformed phenotype.
  • However, the previous work was limited to mouse fibroblast-derived DNA and NIH3T3 recipient cells.

Purpose of the Study:

  • To investigate if tumor-transforming genes can function across different tissue types and species.
  • To determine if DNA from non-fibroblastic tumor lines can induce NIH3T3 cell transformation.

Main Methods:

  • Preparation of DNA from diverse mouse and non-mouse tumor cell lines of non-fibroblastic origin.
  • Transfection of NIH3T3 cells with the prepared tumor DNA.
  • Observation and analysis of NIH3T3 cell transformation foci.

Main Results:

  • DNA from human, rabbit, and mouse bladder carcinoma lines induced NIH3T3 cell transformation.
  • DNA from a lung carcinoma line also demonstrated transforming activity.
  • DNA from rat neuroblastoma and mouse glioma lines successfully transformed NIH3T3 cells.

Conclusions:

  • Tumor-derived DNA contains sequences capable of inducing transformation in NIH3T3 cells.
  • These transforming genes can operate effectively across tissue and species barriers.
  • The study supports the concept of conserved oncogenic pathways across diverse tumor types and organisms.